83R4525 MCK-F
By: Zerwas, Naishtat H.B. No. 838
A BILL TO BE ENTITLED
AN ACT
relating to the monitoring of certain medications provided to
foster children.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 266.001, Family Code, is amended by
adding Subdivision (6) to read as follows:
(6) "Psychotropic drug" has the meaning assigned by
Section 261.111.
SECTION 2. Chapter 266, Family Code, is amended by adding
Section 266.011 to read as follows:
Sec. 266.011. MONITORING USE OF PSYCHOTROPIC DRUG. The
person authorized to consent to medical treatment for a foster
child prescribed a psychotropic drug shall ensure that the child
has an office visit with the prescribing physician at least once
every 90 days to allow the physician to:
(1) appropriately monitor the side effects of the
drug; and
(2) determine whether:
(A) the drug is helping the child achieve the
physician's treatment goals; and
(B) continued use of the drug is appropriate.
SECTION 3. The heading to Subchapter A, Chapter 266, Family
Code, is repealed.
SECTION 4. This Act takes effect September 1, 2013.